Dr Olof Nord is a life science global executive with 25+ years of leadership experience across biotech, biopharma, life science tools, diagnostics and medtech, with extensive responsibility for international commercialization and business development, including an organic and in-organic strategic growth expertise. Before joining ScandiBio Therapeutics, he held senior roles at Abbott, Biotage, Becton Dickinson and Analyticon Biotechnologies, where he led international and regional commercial organizations across USA, Europe, MEA and Asia. He holds both a Master of Science in Chemical Engineering and a Doctoral Degree in Biotechnology, both achieved from the KTH Royal Institute of Technology.